CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Clinical trial NCT05260528 · RECRUITING
Trial details
- NCT number
- NCT05260528
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2028-08-02
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.